FDA Inspection
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited – FDA Inspection, Jun 11, 2009
Record Details
This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on June 11, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 11, 2009
- Product Type
- Biologics
View Company Profile
ID · 8dab6079-805e-47c4-bb6b-42e310fda99c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 599120
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Takeda Pharmaceutical Company Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 14, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 9, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Takeda Pharmaceutical Company Limited
- FDA Inspection 1099764 - 2019-07-30
- FDA Inspection 975877 - 2016-06-15
- FDA Inspection 934717 - 2015-07-09
- FDA Inspection 844248 - 2013-08-14
- FDA Inspection 712228 - 2011-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.